Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction

Circulation. Cardiovascular imaging - United States
doi 10.1161/circimaging.113.000633
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cardiac Troponin and Outcome in Decompensated Heart Failure With Preserved Ejection Fraction

Cardiovascular Diagnosis and Therapy
Cardiovascular MedicineCardiology
2017English

Echocardiographic Patterns of Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Time-Dependent Regional Myocardial Strains in Patients With Heart Failure With a Preserved Ejection Fraction

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Prognostic Role of T1 Mapping Parameters in Patients With Heart Failure With Preserved Ejection Fraction: A Systematic Review

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Ischaemia in Heart Failure With Preserved Ejection Fraction; Is It Important?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2016English

Myocardial Injury and Cardiac Reserve Limitation in Heart Failure With Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Soluble Neprilysin Does Not Correlate With Outcome in Heart Failure With Preserved Ejection Fraction?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2016English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy